SEC Who? Ripple Spits Fire, Buys Back $285M Shares After Legal Win, Plans More

Ripple Labs (CRYPTO: XRP) is set to repurchase $285 million of its shares from early investors and employees, reflecting the company's robust financial standing and

Ripple Labs (CRYPTO: XRP) is set to repurchase $285 million of its shares from early investors and employees, reflecting the company’s robust financial standing and strategic growth plans.

What Happened: The tender offer, which essentially values Ripple Labs at a substantial $11.3 billion, allows investors to sell a maximum of 6% of their holdings, Reuters reported Wednesday. 

Ripple Labs also revealed its intention to allocate an additional $500 million to cover the costs associated with converting restricted stock units into shares and related tax expenses.

Brad Garlinghouse, CEO of Ripple, reportedly said the company possesses over $1 billion in cash and more than $25 billion in crypto assets, predominantly XRP coins.

Ripple Labs plans to conduct further share buybacks regularly to offer liquidity to investors, he said. The company does not foresee a public listing in the U.S. shortly due to ongoing regulatory uncertainties.

Why It’s Important: Ripple’s decision follows a notable victory in its protracted legal battle with the Securities and Exchange Commission.

Also Read: ‘Very Late Step’ In The Game: Cboe Exchange Greenlights ARK 21Shares Bitcoin ETF

A U.S. District Judge ruled in July the sale of XRP on public exchanges does not constitute unregistered securities offerings.

This legal win marks a significant milestone for Ripple.

Founded in 2012, Ripple Labs has been at the forefront of developing a payment system that supports cross-border transactions while advocating for the use of XRP.

The company acquired Switzerland-based crypto custody firm Metaco for $250 million in May of last year.

Garlinghouse highlighted the company’s resilience and growth despite the challenges posed by the SEC lawsuit, noting that 95% of Ripple’s customers are non-U.S. financial institutions.

He did not disclose the specifics of the payment business’ size.

Read Next: Bitcoin Dips Below $45,000 On ETF Approval False Start: ‘There May Not Be A Huge Rally,’ Warns Trading Firm

Photo via Shutterstock.

Total
0
Shares
Related Posts
Read More

Mesoblast and Oaktree Extend Availability Period of Undrawn Tranches of Financing Facility

Mesoblast Limited (NASDAQ:MESO, ASX:MSB))), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that funds managed by Oaktree Capital Management, L.P. ("Oaktree") have extended to Mesoblast the availability of up to an additional US$30.0 million of its US$90 million five year facility subject to achieving certain milestones on or before September 30, 2023.

MESO